Home » Topics » BioWorld

BioWorld
RSS

MIXED RESULTS FROM ANTI-ID TRIALS

Jan. 16, 1992

PMA CRITICIZES BIOTECH BOTTLENECK IN FDA

Jan. 16, 1992

MOUSE ALTERNATIVE TO PANCREAS

Jan. 16, 1992

CENTOCOR/TOCOR II SEEK TO INCREASE OFFERING

Jan. 16, 1992

BIOGEN PROFITABLE FOR THIRD YEAR

Jan. 16, 1992

GTI LICENSES FACTOR IX GENE

Jan. 16, 1992

SWEDEN APPROVES VESTAR'S AMBISOME

Jan. 16, 1992

PTO ALLOWS PROCYTE HAIR-GROWTH PATENT

Jan. 16, 1992

SELL-OFF NICKS TOP-TIER STOCKS

Jan. 16, 1992

CANADA APPROVES GYNEX DRUG CHARGES

Jan. 16, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...